Systemic Lupus Erythematosus![]() Systemic Lupus Erythematosus articles1. Lupus :: Immunosuppressive drug effective for reducing lupus flaresMayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus (SLE). SLE results in inflammation of connective tissues and can involve the skin, joints and kidneys. Its cause is unknown. The findings were announced today at the annual meeting of the American College of Rheumatology in Boston. 2. Lupus :: Despite different triggers of disease, all roads lead to lupus Systemic lupus erythematosus (SLE or lupus) is a chronic autoimmune disease in which the immune system attacks the body?s cells and tissues. 3. Sperm :: Sperm abnormalities seen in male lupus patients The prognosis for systemic lupus erythematosus (SLE), an autoimmune disease that mainly affects women in their reproductive years, has improved recently, prompting a shift toward improving quality of life. For men with SLE, concerns have been raised about their future fertility. 4. Lupus :: Treatment with Belimumab showed improvement in symptoms in 46 percent of lupus patients at 52 weeks Treatment with belimumab resulted in a sustained improvement of systemic lupus erythematosus disease activity in 46 percent of patients at week 52, according to a novel combined responder index in results presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. 5. Lupus :: Over one-third of refractory lupus patients remain stable at long term follow-up Thirty-six percent of patients with refractory systemic lupus erythematosus remain well after undergoing B-cell depletion therapy without needing further standard immunosuppressive agents, according to a study presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. |